CURRICULUM VITAE

More documents

Recommendations

Info

70. Y. Talebkhan , L. Zamaninia, S. Massarrat, F. Mahboudi and M. Mohammadi. 2005.Candidate Helicobacter pylori antigens for serologic screening. Fourth NationalBiotechnology Congress. P. 2671. B. Akhtardanesh, SH. Jamshidi ,S. Sasani ,S. Bokaee ,T. Zahraii and M. Mohammadi.2005. Detection of gastric Helicobacter like organisms in domestic and stray cats inTehran province via PCR. Fourth National Biotechnology Congress. P. 37872. D. Doroud , N. Mohajerani, S. Massarrat, and M. Mohammadi. 2005. Are molecularmethods appropriate substitutions for traditional antimicrobial assays in detectingHelicobacter pylori antibiotic resistance in Iranian clinical trials? Fourth NationalBiotechnology Congress. P. 30373. B. Akhtardanesh, M. Mohammadi, SH. Jamshidi, T. Zahraii, S. Sasani, and S. Bokaee.2005. Identifications of gastric helicobacter Spp in domestic and stray cats in TehranProvince via PCR. Fourth Congress of Iranian Veterinary Clinicians, P. 92-9374. A. Oghalaie, HP Research Group, Clinical Team, M. Eshagh Hosseini, M. A.Mohagheghi and M. Mohammadi. 2005. Cytokine gene expression in gastric cancerpatients via semi-quantitative RT-PCR. Third Regional Conference of Asian PacificOrganization for Cancer Prevention (APOCP) GI Cancer Control. P. 7075. M. Ghaffarpour, HP Research Group, Clinical Team, H.R. Vaziri, M. A. Mohagheghiand M. Mohammadi. 2005. Evaluation of Host Response toward Helicobacter pyloriantigens in gastric adenocarcinoma patients; Significance of anti-CagA and VacAantibodies. Third Regional Conference of Asian Pacific Organization for CancerPrevention (APOCP) GI Cancer Control. P. 59-6076. Y. Talebkhan, N. Mohajerani, HP Research Group, Clinical Team, H.R. Vaziri, M. A.Mohagheghi and M. Mohammadi. 2005. Risk factors in the pathogenesis of gastriccancer among Iranian population. Third Regional Conference of Asian PacificOrganization for Cancer Prevention (APOCP) GI Cancer Control. P. 76-7777. D. Doroud, HP Research Group, Clinical Team, H.R. Vaziri, M. A. Mohagheghi and M.Mohammadi. 2005. Determination of single vs. multi-strain infection in gastric cancervs. non-cancer patients by microbiologic mapping and finger printing. Third RegionalConference of Asian Pacific Organization for Cancer Prevention (APOCP) GI CancerControl. P. 141-14220
78. Y. Talebkhan, HP Research Group, Clinical Team, H.R. Vaziri, M. A. Mohagheghi andM. Mohammadi. 2005. Detection of predominant Helicobacter pylori genotypes amongIranian gastric cancer and non gastric cancer patients. Third Regional Conference ofAsian Pacific Organization for Cancer Prevention (APOCP) GI Cancer Control. P. 179-18079. L. Zamaninia, HP Research Group, Clinical Team, H.R. Vaziri, M. A. Mohagheghi andM. Mohammadi. 2005. Pattern of Helicobacter pylori colonization in the gastricepithelium of gastric cancer and non cancer patients. Third Regional Conference of AsianPacific Organization for Cancer Prevention (APOCP) GI Cancer Control. P. 186-18780. M. Zohari, HP Research Group, Clinical Team, H.R. Vaziri, M. A. Mohagheghi and M.Mohammadi. 2005. Association between pro-inflammatory cytokine genepolymorphism and increased risk of gastric cancer. Third Regional Conference of AsianPacific Organization for Cancer Prevention (APOCP) GI Cancer Control. P. 188-18981. M. Mohammadi, M. Mohagheghi, Y. Talebkhan, B. Yazdizadeh, A. Abdirad, M.Ghaffarpoor, M. Zohari, and F. Mahmoudi. 2004. CagA is not informative of gastriccancer in Iranian Helicobacter pylori infected patients, whereas vacA may be. SixthInternational conference on pathogenesis and host response in Helicobacter infection.Helsingor, Denmark. Published in Helicobacter. Oct, 9(5): 47182. M. Mohammadi. D. Doroud. N. Mohajerani. L. Zamaninia. and L. P. Andersen. 2004.Correlation of the rdxA gene deletion and metronidazole resistance in IranianHelicobacter pylori strains. Sixth International conference on pathogenesis and hostresponse in Helicobacter infection. Helsingor, Denmark. P:3183. M. Mohammadi, D. Doroud, N. Mohajerani, A. Oghalaie, S. Massarrat, M. Farahvash.2003. Clarithromycin Resistance in Iranian Helicobacter pylori Strains; Is it a Drug ofChoice for Iran? 12th International workshop on Campylobacter, Helicobacter andrelated organisms. Aarhus, Denmark. Published in Helicobacter; 8(4): 47184. Y. Talebkhan, R. Sarrami, F. Barkhordari, M. Amani, F. Mahboudi, M. Mohammadi.2003. Cloning, expression and purification of a heterogenic cytotoxin from an IranianHelicobacter pylori strain. 12th International workshop on Campylobacter, Helicobacterand related organisms. Aarhus, Denmark. Published in International Journal of MedicalMicrobiology. 293 (35): 11221
Page 7 and 8: 11. Shabestari Asl, S. Jamshidi, M.
Page 9 and 10: 29. H. Colding , SH. Hartzen , M. M
Page 11 and 12: 5. Y. Talebkhan, M. Esmaili, P. Has
Page 13 and 14: 18. Y. Talebkhan, M. Esmaeili, M. B
Page 15 and 16: International Workshop on Helicobac
Page 17 and 18: 47. M. Mohammadi, A. Oghalaie, M. E
Page 19: 63. D. Doroud, M. Mohammadi, Y. Tal
Page 23: 92. M. Mohammadi, N. Nafisi, A. Ogh

CURRICULUM VITAE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?